糖尿病与超重/肥胖是COVID-19院内严重程度的独立非叠加危险因素:国际多中心回顾性荟萃分析
该国际多中心回顾性荟萃分析纳入11国18中心7244例住院成人COVID-19患者,评估超重、肥胖和糖尿病与院内严重程度的独立关联。结果显示超重与需氧疗/无创通气及有创机械通气风险增加相关,但与院内死亡无关;糖尿病患者中BMI相关风险未进一步叠加。
要点
- 超重与需氧疗/无创通气风险增加相关(aOR 1.44,95%CI 1.15-1.80)。
- 超重与有创机械通气风险增加相关(aOR 1.22,95%CI 1.03-1.46)。
- 糖尿病合并超重/肥胖未额外增加BMI相关的不良结局风险。
核心结论
- 住院成人COVID-19中,超重、肥胖和糖尿病与需呼吸支持风险增加相关,但与死亡无关。
- 糖尿病患者中,COVID-19严重程度风险未超过BMI相关风险。
研究设计与样本
- 国际多中心回顾性研究,从11国18中心医疗记录和区域数据库提取住院成人COVID-19患者数据。
- 采用标准化定义和分析生成各中心估计值,按BMI分类(参考、超重、肥胖)建模结局 odds,调整年龄、性别和预设合并症。
- 对既存糖尿病患者进行亚组分析,各中心估计值通过荟萃分析合并。
主要发现
- 共纳入7244例患者,65.6%为超重/肥胖。
- 超重患者需氧疗/无创通气风险增加(随机效应aOR 1.44,95%CI 1.15-1.80)。
- 超重患者需有创机械通气风险增加(aOR 1.22,95%CI 1.03-1.46)。
- 超重与院内死亡无关联(aOR 0.88,95%CI 0.74-1.04)。
- 肥胖或糖尿病患者中观察到相似效应;糖尿病合并超重/肥胖亚组中任何结局的aOR未额外增加。
临床怎么用
- 对住院COVID-19患者,应关注超重、肥胖和糖尿病作为需呼吸支持的独立危险因素。
- 糖尿病合并超重/肥胖患者的风险评估可参考BMI相关风险,无需额外叠加。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Obesity is an established risk factor for severe coronavirus disease 2019 (COVID-19), but the contribution of overweight and/or diabetes remains unclear. In a multicenter, international study, we investigated if overweight, obesity, and diabetes were independently associated with COVID-19 severity and whether the BMI-associated risk was increased among those with diabetes. RESEARCH DESIGN AND METHODS: We retrospectively extracted data from health care records and regional databases of hospitalized adult patients with COVID-19 from 18 sites in 11 countries. We used standardized definitions and analyses to generate site-specific estimates, modeling the odds of each outcome (supplemental oxygen/noninvasive ventilatory support, invasive mechanical ventilatory support, and in-hospital mortality) by BMI category (reference, overweight, obese), adjusting for age, sex, and prespecified comorbidities. Subgroup analysis was performed on patients with preexisting diabetes. Site-specific estimates were combined in a meta-analysis. RESULTS: Among 7,244 patients (65.6% overweight/obese), those with overweight were more likely to require oxygen/noninvasive ventilatory support (random effects adjusted odds ratio [aOR], 1.44; 95% CI 1.15-1.80) and invasive mechanical ventilatory support (aOR, 1.22; 95% CI 1.03-1.46). There was no association between overweight and in-hospital mortality (aOR, 0.88; 95% CI 0.74-1.04). Similar effects were observed in patients with obesity or diabetes. In the subgroup analysis, the aOR for any outcome was not additionally increased in those with diabetes and overweight or obesity. CONCLUSIONS: In adults hospitalized with COVID-19, overweight, obesity, and diabetes were associated with increased odds of requiring respiratory support but were not associated with death. In patients with diabetes, the odds of severe COVID-19 were not increased above the BMI-associated risk.
引用
- Longmore DK, Miller JE, Bekkering S, et al. Diabetes and Overweight/Obesity Are Independent, Nonadditive Risk Factors for In-Hospital Severity of COVID-19: An International, Multicenter Retrospective Meta-analysis. Diabetes Care. 2021. PMID: 33858854. doi:10.2337/dc20-2676
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。